Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Lokness who wrote (1852)	1/22/2008 11:09:58 AM
From: Jibacoa	Read Replies (1) of 3722

CYTR was down 52.15% at its intraday L, but is down only 18.61% at present.<g>. stockcharts.com It announced today that the FDA has placed on hold its PIIb of arimoclomol for treatment of ALS. Apparently the FDA's decision was based on the need for additional data from previous animal toxicology studies.(So far the drug has been shown to be apparently safe & well tolerated in a study with 185 volunteers.) The stock rebounded today from the $1 level. It doesn't have significant LTD, but trades around 36xBV. The short ratio came down 30%, but still is >11x its ADV.In spite of the significant (triple digit improvements) on revenues in the last 3Qs, CYTR is still expected to have a higher loss in 2008. The Aug 2006 L was $0.81 & the Dec 2002 L $0.32 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next